Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK2 | O00142 | 7/20 | 1.00 |
| ▸ | PYGM | P11217 | 3/20 | 0.67 |
| ▸ | TK1 | P04183 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.65 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sorivudine SCHEMBL4658822 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 | |
| Sorivudine SCHEMBL16555082 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 | |
| Sorivudine SCHEMBL1981707 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 | |
| Sorivudine SCHEMBL3503357 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 | |
| Sorivudine SCHEMBL82640 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 | |
| Sorivudine SCHEMBL16555084 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 | |
| Sorivudine SCHEMBL13413053 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 | |
| Sorivudine SCHEMBL4292930 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 | |
| Sorivudine SCHEMBL3503360 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 | |
| Sorivudine SCHEMBL5511785 | 1.00 | TK2 (1.00) | TK2PYGMTK1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117731769-A | Nucleic acid vaccine for Varicella Zoster Virus (VZV) | 摩登纳特斯有限公司 | 2024-03-22 | — | — | CN | disclosed |
| EP-4301405-A1 | VLP ENTEROVIRAL VACCINES | ModernaTX, Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| CN-117222422-A | Sanopassing polypeptides and their use in the treatment of cancer | 旗舰创业创新五公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-116726203-A | Combination of MRNA encoding immunomodulatory polypeptides and uses thereof | 莫得纳特斯公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-109476718-B | Combination of MRNA encoding immunomodulatory polypeptides and uses thereof | 莫得纳特斯公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-115837014-A | Polynucleotides encoding relaxin | 摩登纳特斯有限公司 | 2023-03-24 | — | — | CN | disclosed |
| CN-109640962-B | Polynucleotides encoding relaxin | 摩登纳特斯有限公司 | 2022-07-19 | — | — | CN | disclosed |
| CN-114404581-A | Cancer vaccine | 摩登纳特斯有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-108430456-B | Cancer vaccine | 摩登纳特斯有限公司 | 2022-01-18 | — | — | CN | disclosed |
| CN-112996854-A | High purity PEG lipids and uses thereof | 摩登纳特斯有限公司 | 2021-06-18 | — | — | CN | disclosed |
| CN-105566304-B | Sulfur-bearing uridine anticancer compound and its intermediate and preparation method | 大连大学 | 2019-04-30 | — | — | CN | disclosed |
| CN-105566304-A | Sulfur-containing uridine anticancer compound and intermediate and preparation method thereof | UNIV DALIAN | 2016-05-11 | — | — | CN | disclosed |
| US-9334300-B2 | Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates | MBC PHARMA, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-7674778-B2 | Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine | ALNYLAM PHARMACEUTICALS (US) | 2010-03-09 | — | — | US | disclosed |